News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
McLoughlin Margaret
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/09/2023 |
4
| McLoughlin Margaret (Director) has filed a Form 4 on Quince Therapeutics, Inc.
Txns:
| Bought 8,000 shares
@ $1.23, valued at
$9.8k
|
|
05/26/2023 |
4
| McLoughlin Margaret (Director) has filed a Form 4 on Quince Therapeutics, Inc.
Txns:
| Granted 27,000 options to buy
@ $1.58, valued at
$42.7k
|
|
06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/09/2020 |
4
| McLoughlin Margaret (Director) has filed a Form 4 on Cortexyme, Inc.
Txns:
| Granted 11,029 options to buy
@ $41.73, valued at
$460.2k
|
|
03/12/2020 |
4
| McLoughlin Margaret (Director) has filed a Form 4 on Cortexyme, Inc.
Txns:
| Bought 550 shares
@ $17, valued at
$9.4k
|
|
05/09/2019 |
4
| McLoughlin Margaret (Director) has filed a Form 4 on Cortexyme, Inc.
Txns:
| Granted 91,911 options to buy
@ $17, valued at
$1.6M
|
|
|
|